Jan 27, 2015· Comment from the American Pharmacists Association· FDA-2014-N-1359-0026
Attached please find the American Pharmacists Association's comments regarding abuse-deterrent formulations of opioid medications.
FDANonrulemakingFDA-2014-N-1359
Development and Regulation of Abuse-Deterrent Formulations of Opioid Medications; Public Meeting
RIN
—
Last modified
Apr 16, 2015
Comment window
closed 4218d ago
American Pharmacists Association (APhA) filings
1
Activity
American Pharmacists Association (APhA) filed 1 comment on this docket between Jan 27, 2015 and Jan 27, 2015. 8 other organizations filed here. The comment window closed 4218d ago.
What American Pharmacists Association (APhA) filed (1)
Abstract
No abstract recorded.
View on regulations.gov →Co-filers (8)
See everyone who commented →- American Pharmacists Association (APhA)THIS ORG1 filing · confidence 97%
- 3M Drug Delivery Systemsunverified attribution1 filing · confidence 70%
- American Osteopathic Associationtrade assoc.1 filing · confidence 85%
- Amneal Pharmaceuticals LLCunverified attribution1 filing · confidence 70%
- Generic Pharmaceutical Associationtrade assoc.1 filing · confidence 85%
- Osmotica Pharmaceutical Corporationunverified attribution1 filing · confidence 70%
- Par Pharmaceutical Incunverified attribution1 filing · confidence 70%
- Pfizer Inc.unverified attribution1 filing · confidence 70%
- US Pain Foundationtrade assoc.1 filing · confidence 85%